EyeGene Inc
KOSDAQ:185490
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
EyeGene Inc
KOSDAQ:185490
|
KR |
|
I
|
I Yuan Precision Industrial Co Ltd
TPEX:2235
|
TW |
|
T
|
Tata Motors Ltd
NSE:TMCV
|
IN |
|
T
|
Twamev Construction and Infrastructure Ltd
NSE:TICL
|
IN |
|
McBride PLC
LSE:MCB
|
UK |
|
DeFi Development Corporation UK PLC
LSE:DFDV
|
UK |
|
A
|
Apex Dynamics Inc
TWSE:4583
|
TW |
|
W
|
WesCan Energy Corp
XTSX:WCE
|
CA |
|
N
|
Nova Technology Corp
TPEX:6613
|
TW |
|
Titan Logix Corp
XTSX:TLA
|
CA |
|
N
|
Neofect Co Ltd
KOSDAQ:290660
|
KR |
|
H
|
High Power Lighting Corp
TPEX:6559
|
TW |
|
Celebrus Technologies PLC
LSE:CLBS
|
UK |
|
P
|
Porvair PLC
LSE:PRV
|
UK |
|
D
|
Daebo Magnetic Co Ltd
KOSDAQ:290670
|
KR |
|
A
|
Appro Photoelectron Inc
TPEX:6560
|
TW |
|
S
|
Syngen Biotech Co Ltd
TPEX:8279
|
TW |
|
A
|
Ali Asghar Textile Mills Ltd
KAR:AATM
|
PK |
|
C
|
Century Insurance Company Ltd
KAR:CENI
|
PK |
|
P
|
Potens Semiconductor Corp
TPEX:7712
|
TW |
|
N
|
NWW Manufacturing Co Ltd
TPEX:2245
|
TW |
Bankruptcy Probability
EyeGene Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
EyeGene Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
E
|
EyeGene Inc
KOSDAQ:185490
|
87.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
168.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
EyeGene Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, EyeGene Inc has total debt of 391.6m KRW. This includes both short-term (0 KRW) and long-term (391.6m KRW) debt.
You can find a full breakdown on its Balance Sheet.
